Physician profile
Anna Kathryn Easterling
NPI 1134579758
$1,576.66
in general payments reported to CMS, 2019-2025
12 companies · $34.67 in 2025
The $34.67 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $720 · 2022: $486 · 2023: $192 · 2024: $143 · 2025: $34.67.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $370.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $370.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $657.91 | 2021-2024 | Rotapro, Avvigo Guidance System, Wolverine Coronary Cutting Balloon |
| Janssen Pharmaceuticals, INC | $318.35 | 2021-2022 | |
| Edwards Lifesciences Corporation | $178.83 | 2022-2024 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Glaxosmithkline, LLC. | $102.79 | 2023-2024 | Rotarix, Pediarix, Bexsero |
| Amgen INC. | $95.55 | 2021-2022 | |
| Biosense Webster, INC. | $85.65 | 2021-2022 | |
| W. L. Gore & Associates, INC. | $40.31 | 2022-2023 | Gore Viabahn Vbx Balloon Expandable Endo |
| Biotronik INC. | $29.49 | 2022 | |
| Sanofi-Aventis U.S. LLC | $21.16 | 2025 | |
| Merck Sharp & Dohme LLC | $16.75 | 2023 | Vaxelis, Gardasil 9, Vaxneuvance |
| Lantheus Medical Imaging, INC. | $16.36 | 2021 | |
| Pfizer INC. | $13.51 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anna Easterling listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.